abstract |
The present invention provides a novel pyrazolo [4,3-c] quinoline derivative exhibiting specific inhibitory activity against microbial β-glucuronidase, and is a potent agent for preventing chemotherapy-induced diarrhea (CID) in cancer. Provides activity. Thus, the compounds of the present invention (1) prevent chemotherapy-induced diarrhea (CID), enhance chemotherapy chemotherapy efficiency, and (2) prevent carcinogens from causing colon cancer. For health food supplements. [Selection] Figure 1 |